‘Double decker’ antibody technology fights cancer
Scientists from The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates…
Browsing: dual variable domain antibody-drug conjugates
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- AACR 2024: How cellular plasticity drives cancer metastasis
- AACR 2024: Proteogenomic signatures may help identify risk of prostate cancer progression in patients with African and European ancestries
- AACR 2024: Investigational personalised vaccine provides clinical benefit for some patients with resected head and neck cancers
- AACR 2024: Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer
- AACR 2024: AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma in phase I trial
- AACR 2024: An exosome-based liquid biopsy shows promise for early detection of pancreatic cancer
- Targeting vulnerability in B-cell development leads to novel drug combination for leukaemia
- The surprising connection between male infertility and family cancer risk